Cargando…
Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides
BACKGROUND: Targeting epitopes derived from neo-antigens (or “neo-epitopes”) represents a promising immunotherapy approach with limited off-target effects. However, most peptides predicted using MHC binding prediction algorithms do not induce a CD8 + T cell response, and there is a crucial need to r...
Autores principales: | Besser, Hanan, Yunger, Sharon, Merhavi-Shoham, Efrat, Cohen, Cyrille J., Louzoun, Yoram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532181/ https://www.ncbi.nlm.nih.gov/pubmed/31118084 http://dx.doi.org/10.1186/s40425-019-0595-z |
Ejemplares similares
-
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017) -
Prediction of Specific TCR-Peptide Binding From Large Dictionaries of TCR-Peptide Pairs
por: Springer, Ido, et al.
Publicado: (2020) -
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
por: Kalaora, Shelly, et al.
Publicado: (2016) -
Contribution of T Cell Receptor Alpha and Beta CDR3, MHC Typing, V and J Genes to Peptide Binding Prediction
por: Springer, Ido, et al.
Publicado: (2021) -
Harvey’s Predecessors and Contemporaries
por: Rolleston, Humphry
Publicado: (1928)